Baird analyst Eric Coldwell maintains Medpace Hldgs (NASDAQ:MEDP) with a Outperform and raises the price target from $302 to $312.
Baird Maintains Outperform on Medpace Hldgs, Raises Price Target to $312
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.